Changes in platelet volume, morphology and RNA content in subjects treated with haemodialysis

References

• De Sanctis L. B., Stefoni S., Cianciolo G., Coli L., Buscaroli A., Feliciangeli G., et al. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation. Int J Artif Organs 1996; 19: 404–10
   PubMedGoogle Scholar
• Opatrny K Jr., Bouda M., Kohoutkova L., Sefrna F. A clinical study to assess the effect of heparin in dialyser rinsing solutions. Int J Artificial Organs 1997; 20: 112–18
   PubMedGoogle Scholar
• Sirolli V., Ballone E., Di Stante S., Amoros L., Bonomini M. Cell activation and cellular‐cellular interactions during hemodialysis: Effect of dialyzer membrane. Int J Artif Organs 2002; 25: 529–37
   PubMed Web of Science ®Google Scholar
• Sebekova K., Spustova V., Optatrny K Jr., Dzurik R. Serotonin and 5‐hydroxyindole‐acetic acid. Bratisl Lek Listy 2001; 102: 351–6
   PubMedGoogle Scholar
• Bartels P. C. M., Schoorl M., Schoorl M. Activatie van stolling tijdens hemodialyse is afhankelijk van de wijze van antistolling. Ned Tijdschr Klin Chem Labgeneesk 2005; 30: 282–4
   Google Scholar
• Schoorl M., Schoorl M., Bartels P. C. M. Platelet activation and serotonin release during treatment with haemodialysis. Ned Tijdschr Klin Chem Labgeneesk 2006; 31: 236–8
   Google Scholar
• Donati G., Ciancolo G., D'Addio F., Colì L., La Manna G., Feliciangeli G., et al. Platelet activation and PDGF‐AB release during dialysis. Int J Artif Organs 2002; 25: 1128–36
   PubMedGoogle Scholar
• Ruf A., Patscheke H. Flowcytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and p‐selectin expression. Semin Thromb Hemostasis 1995; 21: 146–51
   PubMed Web of Science ®Google Scholar
• Kolde H. ‐J. Primary haemostasis. Haemostasis. Pentapharm, Basel 2001; 12–19
   Google Scholar
• Briggs C., Kunka S., Hart D., Oguni S., Machin S. J. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004; 126: 93–9
   PubMed Web of Science ®Google Scholar
• Henning B. F., Zidek W., Linder B., Tepel M. Mean platelet volume and coronary heart disease in hemodialysis patients. Kidney Blood Press Res 2002; 25: 103–8
   PubMedGoogle Scholar
• Ciancolo G., Stefoni S., Donati G., De Pascalis A., Iannelli S., Manna C., et al. Intra‐ and post‐dialytic platelet activation and PDGF‐AB release: Cellulose diacetate vs polysulfone membranes. Nephrol Dial Transplant 2001; 16: 1222–9
   PubMedGoogle Scholar
• Bain B. J. Blood sampling and film preparation/morphology. Blood cells: A practical guide, 2nd edn. 1995; 12 / pp 98–100
   Google Scholar
• Bartels P. C. M., Schoorl M., Schoorl M., Wiering J. G. A., Nubé M. J. Activation of coagulation during treatment with haemodialysis. Scand J Clin Lab Invest 2000; 60: 283–90
   PubMedGoogle Scholar
• Bartels P. C. M., Schoorl M., Schoorl M., Nubé M. J. Deviations in coagulation activation due to treatment with different haemodialysis membranes. Scand J Clin Lab Invest 2003; 63: 417–24
   PubMed Web of Science ®Google Scholar
• Kuragano T., Kuno T., Takahashi Y., Yamamoto C., Nagura Y., et al. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation. Blood Purif 2003; 21: 176–82
   PubMedGoogle Scholar
• Chevallier M., Schoorl M., Schoorl M., van Tellingen A., Nubé M. J., Bartels P. C. M. Membrane dependent activation markers of platelets during treatment with haemodialysis. Ned Tijdschr Klin Chem 2001; 26: 100
   Google Scholar
• Gritters M., Borgdorff P., Grooteman M. P. C., Schoorl M., Schoorl M., Bartels P. C. M., et al. Reduction in platelet activation by citrate anticoagulation does not prevent intradialytic hemodynamic instability. Nephron Clin Pract 2007; 106: c9–16
   Google Scholar
• Ando M., Iwamoto Y., Suda A., Tsuchiya K., Nihei H. New insights into the thrombopoietic status of patients on dialysis through evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood 2001; 97: 915–21
   PubMedGoogle Scholar
• Altun B., Arici M., Haznedaroglu I. C., Usalan C., Erdem Y., Yasavul U., et al. Serum thrombopoietin levels in haemodialysis patients: Involvement of arteriovenous fistula. Nephrol Dial Transplant 1999; 14: 2173–7
   PubMedGoogle Scholar
• Abe Y., Wada H., Tomatsu H., Sakaguchi A., Nishioka J., Yabu Y., et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 2006; 118: 463–9
   PubMed Web of Science ®Google Scholar
• Briggs C., Hart D., Kunk S., Oguni S., Machin S. J. Immature platelet fraction measurement: A future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfusion Med 2006; 16: 101–9
   PubMed Web of Science ®Google Scholar
• Rossi E., Casali B., Regolisti G., Davoli S., Perazzoli F., Negro A., et al. Increased plasma levels of platelet derived growth factor (PDGF BB+PDGF AB) in patients with never‐treated mild essential hypertension. Am J Hypertens 1998; 11: 1239–43
   PubMedGoogle Scholar
• Tassies D., Reverter J. C., Cases A., Escolar G., Villamor N., Lopez‐Pedret J., et al. Reticulated platelets in uremic patients: Effect of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Hematol 1995; 50: 161–6
   PubMed Web of Science ®Google Scholar
• Gresele P., Page C., Fuster V., Vermylen J. Aggregation. Platelets in thrombotic and non‐thrombotic disorders: Pathophysiology, pharmacology and therapeutics, 1st edn. Cambridge University Press, Cambridge 2002; 345
   Google Scholar
• Gritters M., Grooteman M. P. C., Schoorl M., Schoorl M., Bartels P. C. M., Scheffer P. G., et al. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 2006; 21: 153–9
   PubMed Web of Science ®Google Scholar